M. Carpentieri

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

R. Charles Coombes, Emma Hall, Lorna J. Gibson et al. · New England Journal of Medicine · 2004 · 1.8K citations · Full text

Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

R. Charles Coombes, CF Snowdon, Robert Paridaens et al. · The Lancet · 2007 · 905 citations

Tamoxifen Treatment, Clinical Effectiveness, Medicine +8

Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus rifampicin

Luis J. Gonzalez-Montaner, S. Natal, P. Yongchaiyud et al. · Tubercle and Lung Disease · 1994 · 113 citations

Newly-diagnosed Pulmonary Tuberculosis, Pulmonary Tuberculosis, Medicine +5

D-1 receptor supersensitivity in the rat striatum after unilateral 6-hydroxydopamine lesions

M. Buonamici, Carla Caccia, M. Carpentieri et al. · European Journal of Pharmacology · 1986 · 105 citations

Neuroanatomy, Medicine, Neurotransmitter +12

Treatment of Advanced Hormone-Sensitive Breast Cancer in Postmenopausal Women With Exemestane Alone or in Combination With Celecoxib

Luc Dirix, Jorge Ignacio, Shona Nag et al. · Journal of Clinical Oncology · 2008 · 53 citations · Full text